Abstract Toll-like receptors (TLRs) recognize distinct microbial components and induce innate immune responses.
Introduction
Toll-like receptors (TLRs) recognize a variety of microbial components and induce innate immune responses [1] . They are abundantly expressed on 'professional' antigen-presenting cells (APCs) such as macrophages and conventional dendritic cells (DCs) and serve as an important link between the innate and adaptive immune responses. To date, 13 TLRs have been identified in mammals. Bacterial flagellin is a structural protein that forms the main portion of flagella and promotes bacterial chemotaxis and bacterial adhesion to and invasion of host tissues [2] . TLR5 recognizes the conserved domain in flagellin monomers and triggers proinflammatory as well as adaptive immune responses [3, 4] . TLR5 is expressed on the basolateral surfaces of intestinal epithelial cells and is thought to be key in the recognition of invasive flagellated bacteria at the mucosal surface [5] . Human intestinal epithelial cell lines produce chemokines in response to flagellin, leading to subsequent migration of immature DCs [6] . Furthermore, TLR5 is highly expressed in the human lung and a common TLR5 polymorphism in humans causes susceptibility to legionellosis [7, 8] . Although accumulating evidence suggests that TLR5 is critical for host defense against enterobacterial infection, the in vivo function of TLR5 has not been fully elucidated.
Identification of TLR5-expressing cells in the intestine
Unlike other TLR family members, TLR5 is not expressed on macrophages and conventional DCs in mice. Instead, TLR5 is highly expressed in the small intestine [9] . In contrast to the findings of a previous report, TLR5 expression was not high in intestinal epithelial cells (IECs). IECs could not produce any inflammatory cytokines in response to flagellin, although they did produce defencinb3 and CCL27. On the other hand, TLR5 was highly expressed in lamina propria cells (LPCs). TLR family members are preferentially expressed on APCs. In the LP of the mouse small bowel, DCs have been thought to be the dominant APCs. Interestingly, a considerable amount of TLR5 mRNA was detected in CD11c
? LPCs, but none was detected in CD11c -LPCs. Thus, CD11c ? LPCs were identified as TLR5-expressing cells in the intestine (Fig. 1) [9] .
Innate immune responses by CD11c
1 LPCs
Because the intestine is constantly exposed to food antigens (Ags) and commensal bacteria, it is the consensus that most mucosal DCs induce tolerance, but not inflammation. int plasmacytoid DCs exist in these sites [10] . DCs in the Peyer's patch produce interleukin 10 (IL-10) rather than IL-12, polarize naive T cells toward T helper type 2 (Th2) or regulatory T (Treg) cells, and induce the differentiation of immunoglobulin A (IgA)
? plasma cells [11] . Flagellin-stimulated CD11c
? LPCs do not produce IL-10 and tumor-necrosis factor (TNF)-a, but instead produce IL-6 and IL-12 [9] . Furthermore, CD11c
?
LPCs express chemokines, prostaglandins, antimicrobial peptides and molecules involved in cellular adhesion, cytoskeletal organization and intracellular transport in response to flagellin [9] . Accordingly, CD11c ? LPCs have a tendency to induce inflammatory responses rather than tolerance when exposed to flagellin.
Recognition of bacteria by CD11c
1 LPCs TLR4, which is abundantly expressed on innate immune cells such as conventional DCs and macrophages, recognizes lipopolysaccharide (LPS) of Gram-negative bacteria [1] . However, CD11c ? LPCs do not produce any inflammatory cytokines in response to LPS owing to their low expression of TLR [49] . Conventional DCs, which express TLR4 but not TLR5, recognize Gram-negative flagellated bacteria, mainly via TLR4, while TLR4 -TLR5 ? CD11c
?
LPCs produce inflammatory cytokines after exposure to such bacteria [9] . The unique profile of TLR expression in CD11c ? LPCs seems to be closely related to the specific environment in the intestine. Most commensal bacteria in the intestine are Gram-negative anaerobic rod bacteria, which contain LPS in their cell walls. The low expression of TLR4 may allow CD11c
? LPCs to avoid inducing excessive immune responses to commensal bacteria.
Instead, CD11c
? LPCs may induce inflammatory responses to pathogenic flagellated bacteria, which are able to invade the LP, via TLR5. However, some commensal bacteria also have flagella. Recently, it was reported that a-and e-proteobacteria can change the TLR5 recognition site in flagellin without losing flagellar motility [12] . Furthermore, some commensal bacteria in the intestine suppress flagellin expression [13] . Unlike pathogenic bacteria, commensal bacteria may have mechanisms to escape TLR5-mediated host detection in the intestine.
Role of TLR5 in Salmonella typhimurium infection
S. typhimurium is a facultative intracellular pathogenic bacterium that causes typhoid-like disease in mice. In oral infection, S. typhimurium are captured by sub-epithelial DCs after transport through M cells in Peyer's patches (PPs) or intra-epithelial DCs in LPs [14, 15] . After internalization, S. typhimurium inject effector proteins into the cytoplasm via a type III secretion system and inhibit phagosome-lysosome fusion. S. typhimurium can safely replicate in Salmonella-containing vacuoles (Fig. 2) [16] . On the other hand, bacteria-laden DCs undergo maturation and migrate to the T-cell zones of PPs or draining LPCs. Confocal microscopy of frozen tissue sections of the small intestine and Peyer's patch of C57BL/6 mice, fixed and stained with antibodies specific for CD11c (red) and TLR5 (green) [9] mesenteric lymph nodes (MLNs). These mature DCs are also thought to be responsible for the dissemination of S. typhimurium via the blood stream to the liver and spleen [13, 17] . Although CD11c
? LPCs express inflammatory cytokines after exposure to S. typhimurium in vitro, via a TLR5-dependent mechanism, Tlr5 -/-mice showed resistance to oral S. typhimurium infection. The transport of S. typhimurium from the LP to MLNs was impaired in Tlr5 -/-mice. As S. typhimurium could not fully activate and induce maturation of Tlr5 -/-CD11c ? LPCs, migration of bacteria-laden CD11c
? LPCs may be inefficient in Tlr5 -/-mice. S. typhimurium may use CD11c ? LPCs as carriers during systemic infection by inversely utilizing the host defense activity of TLR5 (Fig. 3 ) [9] . CD11b mid subset consists of eosinophils with uniquely shaped nuclei and eosinophilic granules, which express CD80 but not MHC class II (Fig. 4b) [18] . Among the four subsets of CD11c
? LPCs in the mouse small intestine, CD11c hi CD11b hi lamina propria dendritic cells (LPDCs) specifically express TLR5 (Fig. 4c ). This subset produces IL-6 and IL-12 in response to flagellin in a TLR5-dependent manner. However, they did not produce IL-10, TNF-a or IL-23. CD11c
hi CD11b hi LPDCs also express TLR9, and produce IL-6 and IL-12 in response to CpG DNA. In contrast to CD11c hi CD11b hi LPDCs, other CD11c 
TLR5 and intestinal IgA production
The intestine is known as an organ that produces large amounts of secretory IgA [19] . Intestinal gut-associated lymphoid tissues (GALTs) such as PPs, ILFs and MLNs are major sites for generation of IgA ? plasma cells in the intestine. IgA ? plasma cells are induced there via a mechanism dependent on Ag, CD4
? follicular B helper T cells and the formation of germinal centers (GCs) [20] [21] [22] . Suppressive Foxp3
? CD4 ? T cells in PPs can differentiate efficiently into cells with characteristics of follicular B helper T cells, which then participate in the induction of GCs and IgA production in the gut [23] . CD103
? GALT DCs produce retinoic acid (RA), which induces the selective expression of gut homing receptors, such as integrin a4b7 and CCR9, on differentiated IgA ? plasma cells for gut homing [24, 25] . However, differentiation of IgA ? cells does not necessarily require T cell help and GC formation. GALT DC-derived RA and cytokines synergistically act on naïve B cells, leading to the generation of T cell-independent IgA ? cells [25, 26] . Furthermore, some IgM ? B cells, especially peritoneal B1 cells, directly migrate to the gut LP in a sphingosine 1-phosphate (S1P)-dependent manner and differentiate into IgA ? plasma cells in the LP with the help of stroma cells [27] . Commensal bacteria induce natural secretory IgA, and this process is mediated by commensal bacteria-laden DCs [28] . Furthermore, DCs in the small intestinal LP send protrusions into the lumen through an intercellular gap between epithelial cells via a mechanism dependent on the chemokine receptor CX3CR1, and actively sample luminal bacteria [29] IgA class-switch recombination (CSR) is severely impaired in inducible nitric oxide synthase (iNOS)-deficient mice [30] . iNOS regulates the expression of transforming growth factor-b receptor (TGF-bR) II and plays a critical role in T-cell-dependent IgA CSR. iNOS is also involved in T-cell-independent IgA CSR through the production of a proliferation-inducing ligand (APRIL, also called Tnfsf13) and a B-cell-activating factor of the TNF family (BAFF, also called Tnfsf13b (Fig. 5b) [18, 30] .
CD11c
hi CD11b hi LPDCs are critical for the induction of Th responses as well as IgA production in the intestine [18, 33] . Th17 cells have recently emerged as a third T cell subset that produces IL-17, plays an essential role in protection against certain extracellular pathogens and induces inflammation and severe autoimmunity [34] . Differentiation of Th17 cells is initiated by TGF-b and IL-6 (Fig. 6 ) [35] [36] [37] . IL-6 signaling activates STAT3 and the lineagedetermining transcription factor RORct [38] . RORa, another member of the ROR family, is induced in a STAT3-dependent manner and may act synergistically with RORct to induce Th17 cells [39] . IL-21 expression is induced in developing Th17 cells by IL-6. IL-21 acts autocrinely on Th17 cells to amplify this population [40, 41] . IL-23 serves to expand the previously differentiated Th17 cell population [35] . In humans, IL-1 has been reported to be involved in the generation of Th17 cells [42] . In addition, recent reports have shown that interferon regulatory factor (IRF) 4, Runt-related transcription factor 1 (Runx1) and aryl hydrocarbon receptor (AHR) are essential for Th17 cell differentiation [43] [44] [45] [46] . Interestingly, Th17 cells preferentially exist in the intestinal LP of healthy mice [38] . Whereas conventional DCs induce Th1 cells in [30] (b) (a) Fig. 4 Four subsets of CD11c LPCs. a Flow cytometry of intestinal low-density LPCs stained for CD11b and CD11c, before and after sorting. b MayGrunwald-Giemsa staining of four leukocyte subsets (gated in a) from the lamina propria. Scale bars 10 lm. c RT-PCR of Tlr5 expression in the four leukocyte lamina propria subsets. Actb encodes b-actin [18] J Gastroenterol (2009) A series of recent studies showed that RA negatively regulates Th17 cell differentiation [47] [48] [49] . In every study, RA effectively inhibited in vitro differentiation of Th17 cells induced by IL-6 plus TGF-b in a dose-dependent manner. Although CD11c hi CD11b hi LPDCs express RALDH2, they specifically induce Th17 cells [18] . Interestingly, the effect of RA on DC-mediated Th17 cell differentiation differs according to its concentration. RA at high concentration (10 lM) inhibits the differentiation of Th17 cells as well as Th1 cells, suggesting that high concentrations of RA inhibit both Th17 and Th1 cell differentiation induced by LPDCs. On the other hand, the RAR inhibitor LE540 inhibits the differentiation of Th17 cells, but not Th1 cells, suggesting that RA from LPDCs is necessary for Th17 cell differentiation. Interestingly, LPSstimulated SPDCs can induce Th17 cells to the same extent as flagellin-stimulated LPDCs (R2) following the addition of RA at low concentration (1 nM). Furthermore, 10 lM RA abolished Th1 cell differentiation induced by LPSstimulated SPDCs [18] . Thus, RA at low concentrations (1 nM) may have a positive effect on DC-mediated Th17 cell differentiation. According to a previous report, the plasma RA level is usually on the order of 10 nM [24] . It is well known that GALT DCs, but not DCs from other central lymphoid tissues, such as the spleen or peripheral lymph nodes (PLNs), produce RA, which upregulates expression of the chemokine receptor CCR9 and the integrin a 4 b 7 on CD8
? precursors, Ag-specific CTLs, CD4 ? T cells (Th1 and Th 2) and B cells [24, 25, [50] [51] [52] . Iwata et al [24] clearly showed that RA effectively enhanced a4b7 expression on CD8
? T cells even at concentrations in the range 0.1-1 nM. Because CD11c hi CD11b hi LPDCs could induce B220 -IgA ? plasma cells from naïve B cells and CCR9 expression on differentiated plasma cells effectively in vitro, the RA released from LPDCs is functional [18] . Although it is difficult to determine the hi DCs take up pathogenic bacteria during infection, they are activated and induced to maturate via innate immune receptors, leading to the activation of acquired immunity through the induction of proinflammatory cytokines and costimulatory molecules. Thus, CD11c hi CD11b hi DCs may play critical roles in the decision to mount tolerant or protective immune responses in intestine by using innate immune receptors such as TLR5 as switches.
Conclusion
In this review, we have summarized the unique characteristics of TLR5-expressing LPDCs. These DCs induce innate immune responses by recognizing flagellated pathogenic bacteria via TLR5. They also work against bacterial infection by inducing 'local' IgA secretion and 'systemic' T helper responses through TLR5 stimulation (Fig. 7) . Because IL-17 influences various kinds of cells to produce proinflammatory cytokines and induces the activation and migration of neutrophils, CD11c hi CD11b hi LPDCs and Th17 cells may be involved in the pathogenesis of intestinal bowel diseases, such as Crohn's disease. In addition, CD11c hi CD11b hi LPDCs might be useful targets of mucosal vaccination based on their ability to induce Th1 responses and IgA synthesis. Future studies on CD11c hi CD11b hi LPDCs will lead to new medical treatments.
